BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, March 21, 2026
Home » Authors » Catherine Hollingsworth

Articles by Catherine Hollingsworth

RegeneRx Secures $5M for Wound Healing Trials

Feb. 28, 2008
By Catherine Hollingsworth

Receptor Logic Finds Partner to Develop T-Cell Mimics

Feb. 28, 2008
By Catherine Hollingsworth

CollaGenex Being Acquired by Galderma for $420M Cash

Feb. 27, 2008
By Catherine Hollingsworth
CollaGenex Pharmaceuticals Inc. said it has agreed to be acquired by a U.S. affiliate of Galderma Pharma SA for about $420 million. (BioWorld Today)
Read More

CollaGenex Being Acquired by Galderma for $420M Cash

Feb. 27, 2008
By Catherine Hollingsworth
CollaGenex Pharmaceuticals Inc. said it has agreed to be acquired by a U.S. affiliate of Galderma Pharma SA for about $420 million. (BioWorld Today)
Read More

GTx Good News on ADT Gives its Stock a 36 Percent Boost

Feb. 26, 2008
By Catherine Hollingsworth

GTx Good News on ADT Gives its Stock a 36 Percent Boost

Feb. 26, 2008
By Catherine Hollingsworth

Repros' Preparing to Launch Phase III Studies of Proellex

Feb. 25, 2008
By Catherine Hollingsworth

Repros' Preparing to Launch Phase III Studies of Proellex

Feb. 25, 2008
By Catherine Hollingsworth

Affomix Closes $7M Series A for Automatic Antibody Effort

Feb. 22, 2008
By Catherine Hollingsworth

Affomix Closes $7M Series A for Automatic Antibody Effort

Feb. 22, 2008
By Catherine Hollingsworth
Previous 1 2 … 57 58 59 60 61 62 63 64 65 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • Art concept for targeting the brain

    Precision psychiatry beyond, or before, biomarkers

    BioWorld
    There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
  • MRI image brain on black background

    ADPD 2026: Can we prevent dementia? Scientists quantify it

    BioWorld
    Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
  • Illustration of a motor neuron

    Keros reports beneficial effects of RKER-065 in ALS model

    BioWorld Science
    Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
  • First-in-class POLG activator restores mtDNA across mutations

    BioWorld Science
    Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing